Reflections on World Thrombosis Day 2024

 

 Permissions and Reprints

On the occasion of World Thrombosis Day, our four journals: Thrombosis and Haemostasis, TH Open, Seminars in Thrombosis and Hemostasis as well as Hämostaseologie—Progress in Haemostasis join forces in a collaborative editorial to share and emphasize our commitment to advancing research, education, and clinical practice, and reducing the impact of thrombosis worldwide, as an entity that gives rise and contributes to a major part of the morbidity and mortality from cardiovascular diseases and beyond.

We highlight here recent publications from our journals, which we hope will have an impact on understanding and management of thrombosis.

^* These authors serve as co-corresponding authors.

Publication History

Article published online:
13 October 2024

© 2024. Thieme. All rights reserved.

Georg Thieme Verlag KG
Stuttgart · New York

• References

• 1 Sachetto ATA, Mackman N. Monocyte tissue factor expression: lipopolysaccharide induction and roles in pathological activation of coagulation. Thromb Haemost 2023; 123 (11) 1017-1033
  MissingFormLabel

  Thieme ConnectPubMedSearch in Google Scholar
• 2 Rolling CC, Sowa MA, Wang TT. et al. P2Y12 inhibition suppresses proinflammatory platelet-monocyte interactions. Thromb Haemost 2023; 123 (02) 231-244
  MissingFormLabel

  Thieme ConnectPubMedSearch in Google Scholar
• 3 Zou J, Sun S, De Simone I. et al. Platelet activation pathways controlling reversible integrin αIIbβ3 activation. TH Open 2024; 8 (02) e232-e242
  MissingFormLabel

  Thieme ConnectPubMedSearch in Google Scholar
• 4 Bourne JH, Smith CW, Jooss NJ. et al. CLEC-2 supports platelet aggregation in mouse but not human blood at arterial shear. Thromb Haemost 2022; 122 (12) 1988-2000
  MissingFormLabel

  Thieme ConnectPubMedSearch in Google Scholar
• 5 Boccatonda A, Balletta M, Vicari S, Hoxha A, Simioni P, Campello E. The journey through the pathogenesis and treatment of venous thromboembolism in inflammatory bowel diseases: a narrative review. Semin Thromb Hemost 2023; 49 (07) 744-755
  MissingFormLabel

  Thieme ConnectPubMedSearch in Google Scholar
• 6 Romiti GF, Proietti M, Bonini N. et al; GLORIA-AF Investigators. Clinical complexity domains, anticoagulation, and outcomes in patients with atrial fibrillation: a report from the GLORIA-AF registry phase II and III. Thromb Haemost 2022; 122 (12) 2030-2041
  MissingFormLabel

  Thieme ConnectPubMedSearch in Google Scholar
• 7 Chao TF, Chan YH, Chiang CE. et al. Early rhythm control and the risks of ischemic stroke, heart failure, mortality, and adverse events when performed early (<3 months): a nationwide cohort study of newly diagnosed patients with atrial fibrillation. Thromb Haemost 2022; 122 (11) 1899-1910
  MissingFormLabel

  Thieme ConnectPubMedSearch in Google Scholar
• 8 Grymonprez M, Petrovic M, De Backer TL, Steurbaut S, Lahousse L. The impact of polypharmacy on the effectiveness and safety of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Thromb Haemost 2024; 124 (02) 135-148
  MissingFormLabel

  Thieme ConnectPubMedSearch in Google Scholar
• 9 Tafur AJ, Barnes GD, Bhagirath VC, Douketis J. Anticoagulation stewardship to bridge the implementation gap in perioperative anticoagulation management. TH Open 2024; 8 (01) e114-e120
  MissingFormLabel

  Thieme ConnectPubMedSearch in Google Scholar
• 10 Spiezia L, Campello E, Tormene D, Simioni P. Venous thromboembolism in children: the rivaroxaban experience. Semin Thromb Hemost 2024; 50 (06) 866-872
  MissingFormLabel

  Thieme ConnectPubMedSearch in Google Scholar
• 11 Glonnegger H, Glatthaar N, Eckenweiler M. et al. Laboratory findings, medical imaging, and clinical outcome in children with cerebral sinus venous thrombosis. Hamostaseologie 2023; 43 (03) 188-195
  MissingFormLabel

  Thieme ConnectPubMedSearch in Google Scholar
• 12 Pleming W, Barco S, Voci D. et al. Cardiac and cerebral arterial complications of Lemierre syndrome: results from a systematic review and individual patient data meta-analysis. Hamostaseologie 2022; 42 (04) 261-267
  MissingFormLabel

  Thieme ConnectPubMedSearch in Google Scholar
• 13 Gorog DA, Gue YX, Chao TF. et al. Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: executive summary of a European and Asia-Pacific Expert Consensus Paper. Thromb Haemost 2022; 122 (10) 1625-1652
  MissingFormLabel

  Thieme ConnectPubMedSearch in Google Scholar
• 14 Campello E, Bucciarelli P, Catalani F, Erba N, Squizzato A, Poli D. Scientific Reviewer Committee. Anticoagulant therapy in pregnant women with mechanical heart valves: Italian Federation of Centers for Diagnosis and Surveillance of the Antithrombotic Therapies (FCSA) position paper. Thromb Haemost 2024; 124 (08) 695-708
  MissingFormLabel

  Thieme ConnectPubMedSearch in Google Scholar
• 15 Aguirre Del-Pino R, Monahan RC, Huizinga TWJ, Eikenboom J, Steup-Beekman GM. Risk factors for antiphospholipid antibodies and antiphospholipid syndrome. Semin Thromb Hemost 2024; 50 (06) 817-828
  MissingFormLabel

  Thieme ConnectPubMedSearch in Google Scholar
• 16 Benz AP, Xu L, Eikelboom JW. et al; ANNEXA-4 Investigators. Andexanet alfa for specific anticoagulation reversal in patients with acute bleeding during treatment with edoxaban. Thromb Haemost 2022; 122 (06) 998-1005
  MissingFormLabel

  Thieme ConnectPubMedSearch in Google Scholar
• 17 Goldin M, Smith K, Koulas I. et al. Clinical pathways and outcomes of andexanet alfa administration for the reversal of critical bleeding in patients on oral direct factor Xa inhibitors. TH Open 2024; 8 (02) e209-e215
  MissingFormLabel

  Thieme ConnectPubMedSearch in Google Scholar
• 18 Leebeek FWG, Castaman G, Marier JF. et al. Exposure-response relationship between VWF/FVIII activity and spontaneous bleeding events following recombinant VWF prophylaxis in severe VWD. TH Open 2024; 8 (02) e243-e251
  MissingFormLabel

  Thieme ConnectPubMedSearch in Google Scholar
• 19 Khaddam D, McRae HL, Schwarz N. et al. High prevalence of F2 20210G > A in splanchnic vein thrombosis and cerebral venous sinus thrombosis: a retrospective cohort study of patients with thrombosis in atypical sites. Hamostaseologie 2024; (e-pub ahead of print)
  MissingFormLabel

  Thieme ConnectPubMedSearch in Google Scholar
• 20 Verstraete A, Freson K, Verhamme P, Vanassche T. Thrombophilia testing: from genetic predisposition to discrimination. TH Open 2024; 8 (02) e177-e180
  MissingFormLabel

  Thieme ConnectPubMedSearch in Google Scholar
• 21 Uzun G, Althaus K, Hammer S. et al. Diagnostic performance of a particle gel immunoassay in vaccine-induced immune thrombotic thrombocytopenia. Hamostaseologie 2023; 43 (01) 22-27
  MissingFormLabel

  Thieme ConnectPubMedSearch in Google Scholar
• 22 Rolling CC, Mohme M, Bokemeyer C. et al. Circulating tumor cells and thromboembolic events in patients with glioblastoma. Hamostaseologie 2024; (e-pub ahead of print)
  MissingFormLabel

  Thieme ConnectPubMedSearch in Google Scholar
• 23 Romiti GF, Guo Y, Corica B, Proietti M, Zhang H, Lip GYH. mAF-App II trial investigators. Mobile health-technology-integrated care for atrial fibrillation: a win ratio analysis from the mAFA-II randomized clinical trial. Thromb Haemost 2023; 123 (11) 1042-1048
  MissingFormLabel

  Thieme ConnectPubMedSearch in Google Scholar
• 24 El-Sherbini AH, Coroneos S, Zidan A, Othman M. Machine learning as a diagnostic and prognostic tool for predicting thrombosis in cancer patients: a systematic review. Semin Thromb Hemost 2024; 50 (06) 809-816
  MissingFormLabel

  Thieme ConnectPubMedSearch in Google Scholar
• 25 Franchini M, Focosi D, Pezzo MP, Mannucci PM. Catastrophic thrombosis: a narrative review. Semin Thromb Hemost 2024; (e-pub ahead of print)
  MissingFormLabel

  Thieme ConnectPubMedSearch in Google Scholar